Bayer Withdraws from US Settlement Proceedings

Defeat for Bayer boss Werner Baumann in the legal dispute over glyphosate: The responsible US federal judge has rejected the proposed settlement. Bayer is therefore now stepping out of the…

Read More

Bayer is Also Subject to the Second Glyphosate Appeal

The agrochemical and pharmaceutical company Bayer has also suffered a defeat in the second of its US appeals proceedings due to alleged cancer risks of the weed killer glyphosate. The…

Read More

Bayer Made A Loss of More Than 10 Billion Euros

The pharmaceutical and chemical giant has had a difficult year. The settlement of the glyphosate lawsuits in the USA and billions in write-offs in the agricultural business resulted in a…

Read More

Bayer is Investing up to Four Billion Dollars in Gene Therapy Specialists

With its largest acquisition to date in the biotech sector, Bayer aims to become a leading player in gene and cell therapy. The Leverkusen-based group is taking over the non-listed…

Read More

Page 1 of 1